ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,100, issued on Oct. 20, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"In vivo targeting of extracellular vesicles" was invented by Aditya Bansal (Rochester, Minn.), Timothy R. DeGrado (Rochester, Minn.) and Mukesh K. Pandey (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for chemically induced homing of extracellular vesicles (EVs) to a specific tissue or organ in a subject for either treatment or diagnosis of a medical condition, the method comprising administering to the subject an amount of a homing agent. The homing agent is at least one of a derivative of poly(ethylene glycol),...